Welcome to ProLife
a company that promotes LIFE, through Life-Science services
PROLIFE helped us set up the new manufacturing facility with "state of the art" design and futuristic ideas. Through their able guidance, the facility received MHRA accreditation that paved the way for marking a strong footprint in the EEA.
Mr S V Veerramani
CMD, Fourrts (India) Laboratories Pvt Ltd
Life-Science industry has in it a major responsibility - to protect & sustain lives.
This industry covers vast areas ranging from service segment like clinical research centres, hospitals, primary healthcare centres, etc., and supply-chain segment like APIs & Excipient manufacturers, Finished dosage manufacturers, Medical device manufacturers, wholesale distributors, retail pharmacies and so on.
ProLife contributes to the supply-chain segment.
Through thoughtfully crafted business verticals, ProLife covers the entire gamut of this vital segment that powers the Life-Science industry.
The company's promoters and associates have more than 3 decades of experience in this dynamic industry.
Who We Are
Emerged from the vast knowledge possessed by the promoter, Ram Iyer, who had worked in the Life-Science industry for over 25 years, serving various areas of supply chain operations.
The company started its India operations in the year 2006, with an aim of serving the Life-Science industry in the core areas of Manufacturing, QA & Regulatory affairs and Business development in the UK/EU markets.
As a result of constant persuasion from the industry professionals, we added one more business vertical to our core services, that gave birth to our signature training program called PerPharm.
As part of expansion plans, we started our overseas operations in the UK under the name Eunaris, in the year 2016. Through Eunaris, we cater to our overseas clients based in the UK and the wider EEA.
So get on board, to realise your dreams come true, as it did for all our highly satisfied clients!
PROLIFE has vast experience and knowledge in creating world-class facilities and providing support services in regulatory accreditations. We are glad that we chose them to support us in both the areas and thanks to them, we are ahead of our competitors.
CEO, Apex Laboratories Pvt Ltd
The European Falsified Medicines Directive (commonly known as FMD) [2011/62/EU] has been brought in, to address the issue of falsified medicines entering the legitimate medicines supply chain across Europe. Falsified medicines include those with little or no active ingredients, the wrong active ingredients, fake or tampered packaging, and those where products and/or packaging have been stolen for re-use or re-sale.
Under the Directive, all new packs of prescription medicines placed on the market in Europe from February 2019 onwards will have to bear two safety features: a unique identifier(UI) in the form of a 2D data matrix (barcode) and an anti-tamper device (ATD).
Need more awareness on this topic? Get in touch with us.
Does your manufacturing facility have seamless expansion possibilities that can help in reducing plant shut-down?
Are you aware of the recent amendments in the EU-GMP guidelines?
How the regulatory bodies do a "risk-based approach", while planning & scheduling the inspections?